Related Experiment Video
Updated: Jul 9, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
Dissecting eIF4E action in tumorigenesis
Hans-Guido Wendel1, Ricardo L A Silva, Abba Malina
1Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. wendelh@mskcc.org
Abstract:
Genetically engineered mouse models are powerful tools for studying cancer genes and validating targets for cancer therapy. We previously used a mouse lymphoma model to demonstrate that the translation initiation factor eIF4E is a potent oncogene in vivo. Using the same model, we now show that the oncogenic activity of eIF4E correlates with its ability to activate translation and become phosphorylated on Ser 209. Furthermore, constitutively activated MNK1, an eIF4E Ser 209 kinase, promotes tumorigenesis in a manner similar to eIF4E, and a dominant-negative MNK mutant inhibits the in vivo proliferation of tumor cells driven by mutations that deregulate translation. Phosphorylated eIF4E promotes tumorigenesis primarily by suppressing apoptosis and, accordingly, the anti-apoptotic protein Mcl-1 is one target of both phospho-eIF4E and MNK1 that contributes to tumor formation. Our results provide insight into how eIF4E contributes to tumorigenesis and pinpoint a level of translational control that may be suitable for therapeutic intervention.
Insights
The translation initiation factor eIF4E drives cancer by activating translation and suppressing apoptosis. Targeting this oncogenic activity, particularly through its kinase MNK1, offers a potential therapeutic strategy for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Genetically engineered mouse models are crucial for cancer gene research and therapeutic target validation.
- The translation initiation factor eIF4E has been identified as a potent oncogene in vivo.
Purpose of the Study:
- To investigate the correlation between eIF4E's oncogenic activity and its translational control functions.
- To explore the role of MNK1, a kinase for eIF4E, in tumorigenesis.
- To identify therapeutic targets within the eIF4E-mediated translational control pathway.
Main Methods:
- Utilized a previously established mouse lymphoma model.
- Assessed the phosphorylation of eIF4E on Ser 209 and its correlation with oncogenic activity.
- Investigated the effects of constitutively active and dominant-negative MNK1 mutants on tumor cell proliferation.
- Examined the role of the anti-apoptotic protein Mcl-1 as a downstream target.
Main Results:
- The oncogenic activity of eIF4E in vivo is linked to its translation-activating function and Ser 209 phosphorylation.
- Activated MNK1 promotes tumorigenesis similarly to eIF4E.
- A dominant-negative MNK1 mutant suppressed tumor cell proliferation.
- Phosphorylated eIF4E and MNK1 contribute to tumor formation by suppressing apoptosis, partly through regulating Mcl-1.
Conclusions:
- eIF4E contributes to tumorigenesis by enhancing translation and suppressing apoptosis.
- MNK1 plays a significant role in eIF4E-driven tumorigenesis.
- Translational control mediated by eIF4E and MNK1 represents a potential therapeutic intervention point for cancer.
Related Concept Videos
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia
The Tumor Microenvironment
Destabilization of Microtubules

